T
48
3
AAPL
45
3
FLR
48
3
EMN
50
-2
PDCO
30
-6
XRX
34
-3
SIG
47
-2
DUK
50
-2
KEY
46
-2
AON
60
2
REGN
42
-2
FRT
48
2
SYF
93
-2
NRG
50
-2
LEN
52
2
SCHW
65
-2
TXN
49
-6
COF
63
-4
UA
57
4
EQR
60
6
T
48
3
AAPL
45
3
FLR
48
3
EMN
50
-2
PDCO
30
-6
XRX
34
-3
SIG
47
-2
DUK
50
-2
KEY
46
-2
AON
60
2
REGN
42
-2
FRT
48
2
SYF
93
-2
NRG
50
-2
LEN
52
2
SCHW
65
-2
TXN
49
-6
COF
63
-4
UA
57
4
EQR
60
6
Financhill
Back

Cleanspark 10K Form

Buy
72

CLSK
Cleanspark

Last Price:
13.98
Seasonality Move:
93.1%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CLSK News And Ratings

See the #1 stock for the next 7 days that we like better than CLSK

CLSK Financial Statistics

Sales & Book Value

Annual Sales: $169.77M
Cash Flow: $-78.34M
Price / Cash Flow: 0
Annual Sales: $5.95
Price / Book: 3.18

Profitability

EPS (TTM): -0.93000
Net Income (TTM): $-158.48M
Gross Margin: $30.47M
Return on Equity: -15.99%
Return on Assets: -14.98%

Cleanspark Earnings Forecast

Key Cleanspark Financial Ratios

  • The Gross Profit Margin over the past 16 years for CLSK is 17.95%.
  • The Selling, General & Administrative Expenses for CLSK have been equal to 18.67% of Gross Profit Margin.
  • The Research & Development expenses have been 1.60% of Revenue.
  • The Interest Expense is -2.18% of Operating Income.
  • The Net Earning history of CLSK is -80.46% of Total Revenues.
  • Per Share Earnings over the last 16 years have been positive in 8 years.

Cleanspark Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Software
Sector: Information Technology
Current Symbol: CLSK
CUSIP: 18452B
Website: cleanspark.com

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 8.94
Quick Ratio: 8.75

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CLSK Technical Analysis vs Fundamental Analysis

Buy
72
Cleanspark (CLSK) is a Buy

Is Cleanspark a Buy or a Sell?

  • Cleanspark stock is rated a Buy
    The current Cleanspark [CLSK] share price is $14.98. The Score for CLSK is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.